Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal. Larochelle C, Metz I, Lécuyer M-A, Terouz S, Roger M, Arbour N, Brück W, Prat A Mult Scler. 2016 Apr 1. PMID: 27037182. Abstract CommentRecommendBookmarkWatch